BAXTER INTL 17/25BAXTER INTL 17/25BAXTER INTL 17/25

BAXTER INTL 17/25

No trades
See on Supercharts

Key terms


Outstanding amount
‪600.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
1.30% (Fixed)
Coupon frequency
Annual
Yield to maturity
2.94%
Maturity date
May 30, 2025
Term to maturity
6 months

About BAXTER INTL 17/25


Sector
Health Technology
Industry
Medical Specialties
Home page
Issue date
May 30, 2017
ISIN
XS1577962084
FIGI
BBG00GNTNT06
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.